Effect of normobaric and hyperbaric hyperoxia treatment on symptoms and cognitive capacities in Long COVID patients: a randomised placebo-controlled, prospective, double-blind trial
There was no significant effect from different doses of oxygen in a hyperbaric chamber. It is possible that the very modest improvements reported in other studies were due to a placebo effect. Claims that HBOT has a significant effect on Long COVID need further investigation before indiscriminately prescribing or promoting HBOT.
Authors
- Costantino Balestra (ORCID: https://orcid.org/0000-0001-6771-839X)
- Peter Germonpré (ORCID: https://orcid.org/0000-0003-2481-7376)
- Nancy Stevens
- Bert Rinia
- Leonard Caeyers
- Leen D'hoore
Institutions
- Université Libre de Bruxelles (BE)
- European Centre for Ecotoxicology and Toxicology of Chemicals (BE)
- Queen Astrid Military Hospital (BE)
- Haute École de Bruxelles (BE)
Publication Details
- Journal
- Diving and Hyperbaric Medicine Journal
- Published
- 2025-06-18
- DOI
- https://doi.org/10.28920/dhm55.2.104-113
- Citations
- 1
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 1.39